cd38 inhibitor and 5-amino-1mq synergy nad+

cd38 inhibitor and 5-amino-1mq synergy nad+ as theranostic target in oncology | Journal of Translational Medicine New Insights on Muscle Strength:

Name: cd38 inhibitor and 5-amino-1mq synergy nad+ as theranostic target in oncology | Journal of Translational Medicine New Insights on Muscle Strength:
Brand: telecamera-cantiere.com
SKU: 76069221773
Price: 21.57 USD
Availability: InStock
Rating: 4.882000000000001 (24 reviews)

New Insights on Muscle Strength: The Role of Inhibiting an Enzyme that Hinders NAD+ Synthesis Rapid Discovery of CD38 Inhibitor via DNA Encoded Natural Product Library Screening CD38 is a key mediator of NAD+ depletion in the brain of ZIKV infected mice: iScience CD38 Induced Metabolic Dysfunction Primes Multiple Myeloma Cells for NAD+ Lowering Agents

SKU: 76069221773 · From telecamera-cantiere.com

4.9

USD21.57 USD56.57

Pay in 4 interest-free payments of $5.39 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 2 - Aug 7

Description

Vitamin A, D, E, and K

A novel target for next-generation obesity medications is nicotinamide N-methyltransferase (NNMT) 7,8,9,10,11 , an enzyme central to cellular metabolism and energy homeostasis 12